Search

everythinglearnresearchcommunity

for

Search:↓

CEC levels may be a useful marker for predicting prostate cancer progression.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

The document corrects an author's affiliation in previous articles about COVID-19 and its links to hair loss and hormones.

Society's pressure to have children later in life favors genes that increase the risk of early baldness in male offspring.

Balding scalps show different gene expressions affecting hair growth compared to non-balding scalps.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Male mice with FGF5 mutations grow longer hair than females.

Post-Finasteride Syndrome causes lasting sexual, mood, and metabolic issues, needing personalized treatment and better informed consent.

HA-stimulated stem cell vesicles improved hair growth in male mice with androgenetic alopecia.

The meeting covered advances in understanding hair growth, causes of hair loss, and potential treatments.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Hormones and neuropeptides affect hair growth, with androgens having opposite effects on beard and scalp hair.

AGA is caused by genetics and androgens, treatable with finasteride and minoxidil.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Hair loss needs more research for better treatments.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Alopecia and acne in women are complex conditions needing coordinated care and personalized treatment.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.